Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ja Hyun Yeo"'
Autor:
Joo-Hwan Park, Ja Hyun Yeo, Young Saing Kim, Inkeun Park, Hee Kyung Ahn, Eun Kyung Cho, Dong Bok Shin, Jun-Young Yang, Hyung-Sik Kim, Woon Kee Lee, Sun Jin Sym
Publikováno v:
American Journal of Clinical Oncology. 45:61-65
Autor:
Hyera Kim, Jinchul Kim, Jung Yong Hong, Won Ki Kang, Jeeyun Lee, Seung Tae Kim, Ja Hyun Yeo, Seonggyu Byeon, Ho Yeong Lim
Publikováno v:
Targeted Oncology. 15:203-209
A taxane plus ramucirumab as second-line therapy followed by a checkpoint inhibitor (CPI) in third line has become a standard treatment strategy for advanced gastric cancer. Herein, we investigated the impact of prior ramucirumab use on the efficacy
Autor:
Woon-Ki Lee, Joo-Hwan Park, Young Saing Kim, Inkeun Park, Ja Hyun Yeo, Dong Bok Shin, Hee Kyung Ahn, Jun-Young Yang, Hyung Sik Kim, Sun Jin Sym
Publikováno v:
American journal of clinical oncology. 44(6)
Objectives Trastuzumab is used as an agent against human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (AGC). The aim of this study was to determine how HER2 gene amplification and neutrophil-to-lymphocyte ratio (NLR) cou
Autor:
Hee Kyung Ahn, Jeong Ho Kim, Young Saing Kim, Dongbok Shin, Junghan Hwang, S.J. Sym, Ja Hyun Yeo, Joo Hwan Park, Inkeun Park
Publikováno v:
Current problems in cancer. 44(2)
Objective: Malignant tumors around the portal vein (PV) can cause PV stenosis, and PV stent (PVS) placement may reduce symptoms. This study aimed to investigate the efficacy and safety of PVS for symptomatic malignant PV stenosis. Methods: Fourteen c
Autor:
Hyera Kim, Jeeyun Lee, Seung Tae Kim, Ji Yun Lee, Jinchul Kim, Ja Hyun Yeo, Minsuk Kwon, Seonggyu Byeon
Publikováno v:
Journal of Clinical Oncology. 38:e22011-e22011
e22011 Background: There was few data for molecular characteristics of Asian metastatic melanoma patients with distinct clinical features as compared to West patients with metastatic melanoma. We conducted the molecular profiling for Asian metastatic
Autor:
Ho Yeong Lim, Seung Tae Kim, Ja Hyun Yeo, Jung Yong Hong, Joon Oh Park, Se Hoon Park, Jeeyun Lee, Won Ki Kang, Young Suk Park, Jinchul Kim
Publikováno v:
Journal of Clinical Oncology. 38:436-436
436 Background: We established a scoring system using easily approachable clinical characteristics at the timing of initiating palliative chemotherapy to achieve accurate overall survival prediction to first-line treatment consisting of fluoropyrimid